HOLLY SHEA: Open Payments
NPI 1497838825 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $472 · 2025 $818
Food & beverage: $818
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $262 |
| Janssen Biotech, Inc. | 1 | $150 |
| Novartis Pharmaceuticals Corporation | 6 | $144 |
| Incyte Corporation | 2 | $60 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
| Lilly USA, LLC | 2 | $45 |
| UCB, Inc. | 2 | $34 |
| Almirall LLC | 1 | $28 |
| LEO Pharma Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: BOTOX, TREMFYA, SKYRIZI, Rhapsido, OPZELURA, COSENTYX, Zoryve, TALTZ.
Industry payments across CA — which companies pay providers there.
